Why is Lotus Eye Hospit falling/rising?

As of 22-Sep, Lotus Eye Hospital & Institute Ltd is currently priced at 119.25, reflecting a decrease of 0.25, or 0.21%. The stock has been experiencing a downward trend, having fallen consecutively for the last two days, resulting in a total decline of 3.05% during this period. Despite this recent drop, the stock has shown strong performance over the longer term, with a remarkable increase of 73.25% year-to-date and 63.18% over the past year. However, the delivery volume has significantly decreased, falling by 64.09% compared to the 5-day average, indicating reduced investor participation. The company maintains a low debt-to-equity ratio, which is a positive factor, and has consistently outperformed the BSE500 in various timeframes, suggesting strong fundamentals.
In the broader market context, the stock's recent performance contrasts with the Sensex, which has gained 0.46% over the past week. While Lotus Eye Hospital's short-term return of -4.83% over the last week is underperforming relative to the benchmark, its long-term returns remain robust, indicating that the recent decline may be more of a short-term fluctuation rather than a reflection of the company's overall health. The stock's liquidity remains adequate for trading, but the falling investor participation could be a concern for its near-term price stability.